HomeLIPO • NASDAQ
add
Lipella Pharmaceuticals Inc
Previous close
$2.96
Day range
$2.66 - $2.91
Year range
$2.21 - $12.00
Market cap
3.01M USD
Avg Volume
265.60K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 80.38K | -22.75% |
Operating expense | 1.54M | 145.38% |
Net income | -1.44M | -9.15% |
Net profit margin | -1.80K | -41.29% |
Earnings per share | — | — |
EBITDA | -1.46M | -7.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.35M | -43.82% |
Total assets | 2.16M | -23.97% |
Total liabilities | 701.19K | 13.24% |
Total equity | 1.46M | — |
Shares outstanding | 1.09M | — |
Price to book | 2.21 | — |
Return on assets | -167.97% | — |
Return on capital | -219.31% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.44M | -9.15% |
Cash from operations | -653.10K | 5.26% |
Cash from investing | — | — |
Cash from financing | 820.33K | — |
Net change in cash | 167.23K | 123.76% |
Free cash flow | -499.60K | 22.65% |
About
Founded
2005
Headquarters
Website
Employees
5
